サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439232

脳モニタリングデバイス - 世界市場の考察、競合情勢、市場予測（2030年）

Brain Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
脳モニタリングデバイス - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の脳モニタリングデバイスの市場規模は、2023年に63億1,000万米ドル、2030年までに96億1,000万米ドルに達し、2024年～2030年の予測期間にCAGRで7.27％の成長が見込まれます。脳モニタリングデバイスの需要は、主に神経疾患の有病率の上昇、製品開発における技術の進歩、神経変性疾患に対する意識の高まり、臨床試験における脳モニタリングの利用の増加によって後押しされています。低侵襲デバイスに対する需要の高まりと脳モニタリングデバイスの治療応用の拡大は、脳モニタリングデバイス市場の成長をさらに押し上げると予測されます。

脳モニタリングデバイスの市場力学

世界保健機関（WHO）が2023年に提供したデータによると、世界中で約5,000万人がてんかんを患っており、2019年に世界でもっとも一般的な神経疾患の1つとなっています。てんかん患者の約80％は低中所得国に住んでいます。さらに、適切に診断され治療されれば、てんかん患者の最大70％が発作を起こさずに生活できると予測されています。

WHOが2023年に発表したデータによると、約5,500万人が認知症を患っており、毎年1,000万人近くが新たに発症しています。アルツハイマー病はもっとも一般的な認知症であり、症例の60～70％を占めています。

Alzheimer Europe（2019）によると、2050年までに認知症患者数はEUで1,429万8,671人、より広い欧州で1,884万6,286人に増加すると推定されています。

上記のような神経疾患の増加は、治療レジメンの成功可否のモニタリングとともに、疾患の進行のモニタリングに使用されるデバイスに対するより大きな要求をもたらす可能性があります。そのため、脳モニタリングデバイスの需要は予測期間に増加する見込みです。

しかし、新興経済国では必要な医療インフラが整備されておらず、製品や処置に関する安全上の懸念が脳モニタリングデバイス市場の成長に対する一定の抑制要因になる可能性があります。

脳モニタリングデバイス市場のセグメント分析

脳モニタリングデバイス市場の製品タイプセグメントでは、脳波デバイスセグメントが予測期間に最大の市場シェアを占めると予測されています。これは、さまざまな神経疾患の治療におけるEEGデバイスに関連する利点と用途に起因します。

EEGデバイスは、脳活動をリアルタイムで記録するため、てんかんやその他の発作性疾患を含む神経疾患の診断に極めて重要です。てんかん発作間の患者のモニタリング、あるいは発作の予測や制御に役立ちます。

脳波計は睡眠障害の研究にも使用され、睡眠に異常がある場合にそれを特定します。不眠症やその他のストレス関連障害を含む睡眠障害の有無や重症度を検出するのに役立ちます。脳波検査中の睡眠は、脳の活動を総合的に評価することができます。

脳波検査は、患者が脳死または昏睡状態と宣告されなければならない場合の裏付け証拠としても使用されます。

長時間の脳波検査が可能なワイヤレス脳波システムの発売などの技術の進歩も、医療提供者の間でこれらのデバイスの人気が高まる一因となっています。

例えば、MasimoのSedLineはFDAの認可を受けた脳機能モニタリングデバイスであり、臨床医が麻酔下で脳の状態をモニタリングするのに役立ちます。

したがって、絶え間ない技術の進歩とEEGデバイスの応用範囲の拡大が、脳モニタリングデバイス市場のその他の製品タイプの中でもEEGデバイスに明るい見通しを示しています。

北米が脳モニタリングデバイス市場全体を独占すると予測されます。

すべての地域の中で、北米が脳モニタリングデバイス市場で最大のシェアを占めると予測されています。神経疾患の有病率の増加、優れた医療インフラへのアクセス、同地域における主要市場企業のプレゼンスが、予測期間における市場全体の成長を促進する主な影響要因になると予測されています。

当レポートでは、世界の脳モニタリングデバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 脳モニタリングデバイス市場レポートのイントロダクション

第2章 脳モニタリングデバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 脳モニタリングデバイス市場の主な要因の分析

  • 脳モニタリングデバイス市場の促進要因
    • 神経疾患の有病率の上昇
    • 神経変性疾患に対する意識の高まり
    • 製品開発における技術の進歩
    • 臨床試験における脳モニタリングの利用の増加
  • 脳モニタリングデバイス市場の抑制要因と課題
    • 新興経済国における先進の医療インフラの欠如
    • 製品や処置に関する安全上の懸念
  • 脳モニタリングデバイス市場の機会
    • 非侵襲性脳モニタリングデバイスへの需要の高まり
    • 製品の安全性の向上

第5章 脳モニタリングデバイス市場のポーターのファイブフォース分析

第6章 脳モニタリングデバイス市場のレイアウト

  • 製品タイプ別
    • 脳波検査（EEG）デバイス
    • 脳磁図（MEG）デバイス
    • 筋電図検査（EMG）デバイス
    • 経頭蓋ドップラー
    • 頭蓋内圧モニタリングデバイス
    • その他
  • デバイスタイプ別
    • 侵襲性
    • 非侵襲性
  • 用途別
    • てんかん
    • パーキンソン病
    • アルツハイマー病
    • 脳卒中
  • エンドユーザー別
    • 病院
    • 診断センター
  • 地域別
    • 北米の脳モニタリングデバイス市場（2021年～2030年）
    • 欧州の脳モニタリングデバイス市場（2021年～2030年）
    • アジア太平洋の脳モニタリングデバイス市場（2021年～2030年）
    • その他の地域の脳モニタリングデバイス市場（2021年～2030年）

第7章 脳モニタリングデバイスの企業と製品のプロファイル

  • Medtronic
  • Nonin
  • Raumedic AG
  • Edwards Lifesciences Corporation
  • BrainScope Company Inc
  • NIHON KOHDEN CORPORATION
  • Neurosoft
  • Advanced Brain Monitoring Inc
  • Rimed
  • Masimo
  • NeuroWave Systems Inc
  • Compumedics Limited
  • Spiegelberg GmbH & Co. KG
  • NOVASIGNAL CORPORATION

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Brain Monitoring Devices Market in Global (2021-2030)
  • Table 3: Brain Monitoring Devices Market in Global by Product Type (2021-2030)
  • Table 4: Brain Monitoring Devices Market in Global by Device Type (2021-2030)
  • Table 5: Brain Monitoring Devices Market in Global by Application (2021-2030)
  • Table 6: Brain Monitoring Devices Market in Global by End-User (2021-2030)
  • Table 7: Brain Monitoring Devices Market in Global by Geography (2021-2030)
  • Table 8: Brain Monitoring Devices Market in North America (2021-2030)
  • Table 9: Brain Monitoring Devices Market in the US (2021-2030)
  • Table 10: Brain Monitoring Devices Market in Canada (2021-2030)
  • Table 11: Brain Monitoring Devices Market in Mexico (2021-2030)
  • Table 12: Brain Monitoring Devices Market in Europe (2021-2030)
  • Table 13: Brain Monitoring Devices Market in France (2021-2030)
  • Table 14: Brain Monitoring Devices Market in Germany (2021-2030)
  • Table 15: Brain Monitoring Devices Market in the United Kingdom (2021-2030)
  • Table 16: Brain Monitoring Devices Market in Italy (2021-2030)
  • Table 17: Brain Monitoring Devices Market in Spain (2021-2030)
  • Table 18: Brain Monitoring Devices Market in Rest of Europe (2021-2030)
  • Table 19: Brain Monitoring Devices Market in Asia-Pacific (2021-2030)
  • Table 20: Brain Monitoring Devices Market in China (2021-2030)
  • Table 21: Brain Monitoring Devices Market in Japan (2021-2030)
  • Table 22: Brain Monitoring Devices Market in India (2021-2030)
  • Table 23: Brain Monitoring Devices Market in Australia (2021-2030)
  • Table 24: Brain Monitoring Devices Market in South Korea (2021-2030)
  • Table 25: Brain Monitoring Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Brain Monitoring Devices Market in the Rest of the World (2021-2030)
  • Table 27: Brain Monitoring Devices Market in the Middle East (2021-2030)
  • Table 28: Brain Monitoring Devices Market in Africa (2021-2030)
  • Table 29: Brain Monitoring Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Brain Monitoring Devices Market in Global (2021-2030)
  • Figure 3: Brain Monitoring Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Brain Monitoring Devices Market in Global by Device Type (2021-2030)
  • Figure 5: Brain Monitoring Devices Market in Global by Application (2021-2030)
  • Figure 6: Brain Monitoring Devices Market in Global by End-User (2021-2030)
  • Figure 7: Brain Monitoring Devices Market in Global by Geography (2021-2030)
  • Figure 8: Brain Monitoring Devices Market in North America (2021-2030)
  • Figure 9: Brain Monitoring Devices Market in the US (2021-2030)
  • Figure 10: Brain Monitoring Devices Market in Canada (2021-2030)
  • Figure 11: Brain Monitoring Devices Market in Mexico (2021-2030)
  • Figure 12: Brain Monitoring Devices Market in Europe (2021-2030)
  • Figure 13: Brain Monitoring Devices Market in France (2021-2030)
  • Figure 14: Brain Monitoring Devices Market in Germany (2021-2030)
  • Figure 15: Brain Monitoring Devices Market in the United Kingdom (2021-2030)
  • Figure 16: Brain Monitoring Devices Market in Italy (2021-2030)
  • Figure 17: Brain Monitoring Devices Market in Spain (2021-2030)
  • Figure 18: Brain Monitoring Devices Market in the Rest of Europe (2021-2030)
  • Figure 19: Brain Monitoring Devices Market in Asia-Pacific (2021-2030)
  • Figure 20: Brain Monitoring Devices Market in China (2021-2030)
  • Figure 21: Brain Monitoring Devices Market in Japan (2021-2030)
  • Figure 22: Brain Monitoring Devices Market in India (2021-2030)
  • Figure 23: Brain Monitoring Devices Market in Australia (2021-2030)
  • Figure 24: Brain Monitoring Devices Market in South Korea (2021-2030)
  • Figure 25: Brain Monitoring Devices Market in the Rest of Asia-Pacific (2021-2030)
  • Figure 26: Brain Monitoring Devices Market in the Rest of the World (2021-2030)
  • Figure 27: Brain Monitoring Devices Market in the Middle East (2021-2030)
  • Figure 28: Brain Monitoring Devices Market in Africa (2021-2030)
  • Figure 29: Brain Monitoring Devices Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0017

Brain Monitoring Devices Market By Product Type (Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Electromyography (EMG) Devices, Transcranial Doppler, Intracranial Pressure Monitoring Devices, and Others), Device Type (Invasive and Non Invasive), Application (Epilepsy, Parkinson's Disease, Alzheimer's Disease, Strokes, and Others), End-User (Hospitals, Diagnostic Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of neurological diseases and rising application of brain monitoring in clinical trials

Global Brain Monitoring Devices Market was valued at USD 6.31 billion in 2023, growing at a CAGR of 7.27% during the forecast period from 2024 to 2030, to reach USD 9.61 billion by 2030. The demand for brain monitoring devices is primarily being boosted by the rising prevalence of neurological diseases, technological advancement in product development, rising awareness about neurodegenerative diseases, and increasing applications of brain monitoring in clinical trials. The growing demand for minimally invasive devices and the expanded therapeutic applications of brain monitoring devices are further expected to boost the brain monitoring devices market growth.

Brain Monitoring Devices Market Dynamics:

According to the data provided by the World Health Organization (WHO) 2023, approximately 50 million people across the globe were suffering from epilepsy, making it one of the most common neurological diseases globally in 2019. About 80% of people with epilepsy live in low- and middle-income countries. Furthermore, it is predicted that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated.

As per the data provided by WHO 2023, about 55 million people are living with dementia, and there are nearly 10 million new cases every year. Alzheimer's disease is the commonest form of dementia and contributes to 60-70% of cases.

According to Alzheimer Europe 2019, it has been estimated that by 2050 the number of people with dementia will increase to 14,298,671 in the EU and 18,846,286 in the wider European region.

The rising number of neurological diseases such as those mentioned above would result in the greater requirement for devices used in monitoring disease progression along with the monitoring of treatment regimens being successful or not. Therefore, the demand for brain monitoring devices is expected to witness an increase in the forecast period.

However, the non-availability of the required healthcare infrastructure in developing economies, and safety concerns regarding products and procedures may prove to be certain restraints to the brain monitoring devices market growth.

Brain Monitoring Devices Market Segment Analysis:

Brain Monitoring Devices by Product Type (Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Electromyography (EMG) Devices, Transcranial Doppler, Intracranial Pressure Monitoring Devices, and Others), Device Type (Invasive And Non Invasive), Application (Epilepsy, Parkinson's Disease, Alzheimer's Disease, Strokes, and Others), End-User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the brain monitoring devices market, the electroencephalography (EEG) devices segment is expected to account for the largest market share during the forecast period. This can be attributed to the advantages and applications associated with EEG devices in the treatment of various neurological diseases.

EEG devices are crucial for the diagnosis of neurological conditions including epilepsy and other seizure disorders as they record brain activity in real time. It assists in the monitoring of patients between epileptic episodes, or to predict and control seizures.

EEG devices are also employed in studying sleep disorders for the identification of any sleep abnormality if present. They help detect the presence and severity of sleep disorders including insomnia and other stress-related disorders. Sleep during an EEG allows for a comprehensive evaluation of brain activity.

EEG studies are also used as supportive evidence in cases where a patient has to be declared brain dead or is in a coma.

Technological advancements such as the launch of wireless EEG systems where long-term EEG studies can be carried out have also contributed to the rising popularity of these devices among healthcare providers.

For example, SedLine by Masimo is FDA cleared brain function monitoring device that helps clinicians monitor the state of the brain under anesthesia, with bilateral acquisition and processing of four leads of electroencephalogram (EEG) signals.

Therefore, the constant technological advancements coupled with the extended application of EEG devices present a positive outlook for EEG devices among other product types in the brain monitoring devices market.

North America is expected to dominate the overall Brain Monitoring Devices Market:

Among all the regions, North America is expected to account for the largest share of the brain monitoring devices market. The growing prevalence of neurological diseases, access to better healthcare infrastructure coupled with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.

As per the data provided by Parkinson's Foundation 2022, about one million people are living with Parkinson's disease (PD) in the US in 2021. This is expected to rise to 1.2 million by 2030. It has been estimated that approximately 60,000 Americans are diagnosed with PD each year. Near bout four percent of people with PD are diagnosed before age 50.

According to the Centers for Disease Prevention and Control (CDC) 2020, there were about 61,000 traumatic brain injury (TBI)-related deaths in the United States in 2019. These statistics point toward the rising number of cases associated with neurological indications.

Considering the presence of a large patient pool in the US coupled with increasing product development activities, the market for brain monitoring devices looks promising in the United States.

For example in August 2020, Masimo received FDA clearance for O3® Regional Oximetry for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult patients.

Furthermore, the presence of key players such as Edward Lifesciences Corporation and Medtronic among others and their initiatives to raise awareness on neurological disorders and their management could increase the adoption of brain monitoring devices in the US thus bolstering the market.

Brain Monitoring Devices Market Key Players:

Some of the key market players operating in the brain monitoring devices market include NONIN, Raumedic AG, Masimo, Natus Medical Incorporated, Edwards Lifesciences Corporation, Neurosoft, Advanced Brain Monitoring, Inc, BrainScope Company Inc, Medtronic, NIHON KOHDEN CORPORATION, NeuroWave Systems Inc, Compumedics Limited, Spiegelberg GmbH & Co. KG, Rimed, NOVASIGNAL CORPORATION, and others.

Recent Developmental Activities in Brain Monitoring Devices Market:

In April 2021, Integra LifeSciences Corporation received a 510(k) clearance by the US Food and Drug Administration for CereLink ICP Monitor. This device is intended to be used as an interface between standard physiological pressure monitoring systems and compatible strain-gauge-type pressure transducers.

In March 2021, Brain Scientific Inc received a 510(k) clearance for its next-generation NeuroCap(TM) device. This device is an advanced Electroencephalogram (EEG) electrode array that is employed in routine clinical and research settings to obtain rapid EEGs where STAT EEG recordings are desired.

In February 2020, Compumedics Limited received a 510k clearance from the US FDA for their Orion LifeSpan MEG. This device is equipped to non-invasively measure the magnetoencephalographic (MEG) signals with the option to measure electroencephalographic (EEG) signals as well which are produced by electrically active tissue of the brain.

Key Takeaways from the Brain Monitoring Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the brain monitoring devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Brain Monitoring Devices Market.

Various opportunities available for the other competitor in the Brain Monitoring Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current brain monitoring devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for brain monitoring devices market growth in the coming future?

Target Audience who can be benefited from this Brain Monitoring Devices Market Report Study

Brain Monitoring Devices products providers

Research organizations and consulting companies

Brain Monitoring Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in brain monitoring devices

Various End-users who want to know more about the Brain Monitoring Devices market and the latest technological developments in the Brain Monitoring Devices market.

Frequently Asked Questions for Brain Monitoring Devices Market:

What is a Brain Monitoring Device?

A brain monitoring device helps in the assessment and monitoring of brain function wherein they help in the monitoring of different parameters. EEG, MEG, and functional MRI are a few common brain monitoring devices available in the brain monitoring products market among others.

What is the market for Global Brain Monitoring Devices?

Global Brain Monitoring Devices Market was valued at USD 6.31 billion in 2023, growing at a CAGR of 7.27% during the forecast period from 2024 to 2030, to reach USD 9.61 billion by 2030.

What are the drivers for Global Brain Monitoring Devices Market?

The major drivers of the global brain monitoring devices market growth are the rising prevalence of neurological diseases, growing awareness about neurodegenerative diseases, and the expansion of brain monitoring devices to therapeutic applications among other contributing factors.

What are the key players operating in Global Brain Monitoring Devices Market?

Some of the important market players operating in the brain monitoring devices market include NONIN, Raumedic AG, Masimo, Natus Medical Incorporated, Edwards Lifesciences Corporation, Neurosoft, Advanced Brain Monitoring, Inc, BrainScope Company Inc, Medtronic, NIHON KOHDEN CORPORATION, NeuroWave Systems Inc, Compumedics Limited, Spiegelberg GmbH & Co. KG, Rimed, NOVASIGNAL CORPORATION, and others.

What regions have the highest share in the Brain Monitoring Devices market?

North America is expected to dominate the overall Brain Monitoring Devices market during the forecast period, 2024 to 2030. The high revenue domination across regions by North America can be attributed to the prevalence of neurodegenerative diseases, access to better healthcare infrastructure in the region majorly in the US and Canada along with the presence of major market players in the region. These are expected to be the major influencing factors in driving the overall growth of the brain monitoring devices market over the forecast period.

Table of Contents

1. Brain Monitoring Devices Market Report Introduction

2. Brain Monitoring Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at a Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Brain Monitoring Devices Market Key Factors Analysis

  • 4.1. Brain Monitoring Devices Market Drivers
    • 4.1.1. Rising Prevalence of Neurological Diseases
    • 4.1.2. Rising Awareness Regarding Neurodegenerative Diseases
    • 4.1.3. Technological Advancements in Product Development
    • 4.1.4. Increasing Application of Brain Monitoring in Clinical Trials
  • 4.2. Brain Monitoring Devices Market Restraints and Challenges
    • 4.2.1. Lack of Advanced Healthcare Infrastructure in Developing Economies
    • 4.2.2. Product and Procedure related Safety Concerns
  • 4.3. Brain Monitoring Devices Market Opportunities
    • 4.3.1. Growing Demand for Non-Invasive Brain Monitoring Devices
    • 4.3.2. Improving Product Safety

5. Brain Monitoring Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Brain Monitoring Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Electroencephalography (EEG) Devices
    • 6.1.2. Magnetoencephalography (MEG) Devices
    • 6.1.3. Electromyography (EMG) Devices
    • 6.1.4. Transcranial Doppler
    • 6.1.5. Intracranial Pressure Monitoring Devices
    • 6.1.6. Others
  • 6.2. By Device Type
    • 6.2.1. Invasive
    • 6.2.2. Non-Invasive
  • 6.3. By Application
    • 6.3.1. Epilepsy
    • 6.3.2. Parkinson's Disease
    • 6.3.3. Alzheimer's Disease
    • 6.3.4. Strokes
    • 6.3.5. Others
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic Centers
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America Brain Monitoring Devices Market in USD million(2021-2030)
      • 6.5.1.1. United States Brain Monitoring Devices Market in USD million(2021-2030)
      • 6.5.1.2. Canada Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.1.3. Mexico Brain Monitoring Devices Market in USD million (2021-2030)
    • 6.5.2. Europe Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.1. France Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.2. Germany Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.4. Italy Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.5. Spain Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Brain Monitoring Devices Market in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.1. China Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.2. Japan Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.3. India Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.4. Australia Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.5. South Korea Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Brain Monitoring Devices Market in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.4.1. Middle East Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.4.2. Africa Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.4.3. South America Brain Monitoring Devices Market in USD million (2021-2030)

7. Brain Monitoring Devices Company and Product Profiles

  • 7.1. Medtronic
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Nonin
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Raumedic AG
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4 Natus Medical Incorporated7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Edwards Lifesciences Corporation
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. BrainScope Company Inc
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. NIHON KOHDEN CORPORATION
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Neurosoft
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Advanced Brain Monitoring Inc
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Rimed
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Masimo
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. NeuroWave Systems Inc
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Compumedics Limited
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Spiegelberg GmbH & Co. KG
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. NOVASIGNAL CORPORATION
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us